TIGIT and cancer: TIGIT and PD-1 high co-expression was observed in PBLs (peripheral blood lymphocytes), MALs (malignant ascites lymphocytes), and TILs with increased frequency in tumor proximity in matched samples of patients at first diagnosis of ovarian cancer not treated (129).